Karo Pharma AB
Develops and sells everyday healthcare products, focusing on OTC and skin health in Europe.
KARO | ST
Overview
Corporate Details
- ISIN(s):
- NO0010308240 (+4 more)
- LEI:
- 213800G54Z51LOPGTA79
- Country:
- Sweden
- Address:
- BOX 16184, 103 24 STOCKHOLM
- Website:
- https://www.karohealthcare.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Karo Healthcare (formerly Karo Pharma AB) is a healthcare company focused on providing 'smart choices for everyday healthcare.' The company develops, acquires, and commercializes a diverse portfolio of branded products, including over-the-counter (OTC) medicines, consumer health goods, and prescription pharmaceuticals, with a strategic emphasis on skin health. Its mission is to empower consumers to prevent illness and treat common health problems. Karo Healthcare's products are available in over 90 countries, with Europe and the Nordic region serving as its core markets. The company pursues growth through a consumer-centric, omnichannel strategy, combining organic innovation with strategic acquisitions to expand its brand portfolio and global presence.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-05-31 16:00 |
Post-Annual General Meeting Information
Kommuniké från Karo Pharmas årsstämma 2022
|
Swedish | 1.4 MB | ||
| 2022-05-27 16:00 |
Pre-Annual General Meeting Information
Ändringar i Karo Intressenter AB:s förslag avseende val av styrelse till Karo P…
|
Swedish | 1.1 MB | ||
| 2022-05-02 18:30 |
Pre-Annual General Meeting Information
KALLELSE TILL ÅRSSTÄMMA I KARO PHARMA AKTIEBOLAG
|
Swedish | 4.9 MB | ||
| 2022-04-19 08:30 |
Share Issue/Capital Change
Karo Pharmas företrädesemission fulltecknad
|
Swedish | 3.6 MB | ||
| 2022-04-19 08:30 |
Share Issue/Capital Change
Karo Pharma’s rights issue fully subscribed
|
English | 3.6 MB | ||
| 2022-04-01 13:30 |
M&A Activity
Karo Pharma slutför förvärvet av E45® från Reckitt
|
Swedish | 21.3 KB | ||
| 2022-04-01 13:30 |
M&A Activity
Karo Pharma completes the acquisition of the E45® brand from Reckitt
|
English | 46.1 KB | ||
| 2022-03-23 12:00 |
Delisting Announcement
Karo Pharma offentliggör prospekt avseende företrädesemissionen och erhåller go…
|
Swedish | 460.3 KB | ||
| 2022-03-23 12:00 |
Report Publication Announcement
Karo Pharma publishes prospectus relating to the rights issue and receives appr…
|
English | 438.3 KB | ||
| 2022-03-16 08:00 |
Share Issue/Capital Change
Karo Pharma resolves on a fully guaranteed rights issue of approximately SEK 2.…
|
English | 156.1 KB | ||
| 2022-03-16 08:00 |
Share Issue/Capital Change
Karo Pharma beslutar om en fullt garanterad företrädesemission om cirka 2,5 mil…
|
Swedish | 156.3 KB | ||
| 2022-03-10 14:00 |
Delisting Announcement
Karo Pharma receives approval to delist the Company’s share from Nasdaq Stockho…
|
English | 697.2 KB | ||
| 2022-03-10 14:00 |
Delisting Announcement
Karo Pharma erhåller villkorat godkännande om avnotering av Bolagets aktier frå…
|
Swedish | 696.0 KB | ||
| 2022-03-09 12:00 |
Delisting Announcement
Karo Pharma applies for delisting of the Company’s shares from Nasdaq Stockholm…
|
English | 51.0 KB | ||
| 2022-03-09 12:00 |
Delisting Announcement
Karo Pharma ansöker om avnotering av Bolagets aktier från Nasdaq Stockholm i sa…
|
Swedish | 51.7 KB |
Automate Your Workflow. Get a real-time feed of all Karo Pharma AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Karo Pharma AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
